Skip to content

Pharminent

cropped-banner_frontpage_2026-07-11-2.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • M&A / Deals
  • LG AI Research and D&D Pharmatech sign agreement for oral peptide drugs
  • M&A / Deals

LG AI Research and D&D Pharmatech sign agreement for oral peptide drugs

Pharmaceutical Business Review

Executives from both organisations, including LG AI Research head Woohyung Lim and D D Pharmatech CEO Seulki Lee, attended the event to formalise the partnership.

Read full story

pharminent June 18, 2026 (Last updated: June 19, 2026)

Pharmaceutical Business Review

Executives from both organisations, including LG AI Research head Woohyung Lim and D D Pharmatech CEO Seulki Lee, attended the event to formalise the partnership.

Read full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: Biogen pens $1bn deal to buy immunology biotech RayThera
Next: GSK claims FDA okay for first oral carbapenem antibiotic

Related Stories

  • M&A / Deals

Teva and Polpharma Biologics sign global deal for ocrelizumab biosimilar

pharminent July 10, 2026
  • M&A / Deals

GSK ends dementia alliance with Alector after setbacks

pharminent July 9, 2026
  • M&A / Deals

AstraZeneca, GSK intensify China ties with Sino Biopharm deals

pharminent July 8, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.